Bayer Pharma AG
General
Total Cases72
Active Cases14
Patents2
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
D
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/05/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,6539,218 B2; 10,828,310 B2. (Attachments: # [1] Order)(nms) (Entered: 11/05/2024) | |
| 11/05/24 | SO ORDERED Granting Stipulation of Dismissal (D.I. 326 in 21-md-3017-RGA-LDH; D.I. 18 in 24-cv-588-RGA) (*Hetero Labs Limited and Ascent Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 11/5/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00588-RGA(nms) (Entered: 11/05/2024) | |
| 11/05/24 | STIPULATION of Dismissal with prejudice as to Defendants Ascent Pharmaceuticals Inc. and Hetero Labs Limited (C.A. 24-588), by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/5/2024 (nms). (Entered: 11/05/2024) | |
| 11/05/24 | CASE CLOSED per entry of D.I. [19] . (nms) (Entered: 11/05/2024) | |
| 10/25/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,539,218 B2; US 10,828,310 B2. (nms) (Entered: 10/25/2024) | |
| 10/25/24 | SO ORDERED Granting [76] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/25/2024. (nms) (Entered: 10/25/2024) | |
| 10/24/24 | STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 10/24/2024) | |
| 10/24/24 | SO ORDERED, re [17] STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 11/6/2024). Signed by Judge Richard G. Andrews on 10/24/2024. (nms) (Entered: 10/24/2024) | |
| 10/23/24 | STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/24/2024 (nms). (Entered: 10/23/2024) | |
| 10/22/24 | REDACTED VERSION of [73] Stipulation, filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 10/22/2024 (nms). (Entered: 10/22/2024) |